Reduced guanine nucleotide-stimulated polyphosphoinositide specific phospholipase C in platelet hyperaggregation in IDDM.

[1]  H. Wadenvik,et al.  Evaluation of platelet reactivity in diabetes mellitus. , 2009, Acta medica Scandinavica.

[2]  A. Vinik,et al.  Low molecular weight GTP-binding proteins are altered in platelet hyperaggregation in IDDM. , 1993, Oncogene.

[3]  W. Siess,et al.  Functional relationship between cyclic AMP-dependent protein phosphorylation and platelet inhibition. , 1990, Advances in experimental medicine and biology.

[4]  Eduarde G. Lapetina,et al.  The signal transduction induced by thrombin in human platelets , 1990, FEBS letters.

[5]  J. Fain.  Regulation of phosphoinositide-specific phospholipase C. , 1990, Biochimica et biophysica acta.

[6]  J. Darbon,et al.  The respective 27 kDa and 28 kDa protein kinase C substrates in vascular endothelial and MCF-7 cells are most probably heat shock proteins. , 1990, Biochemical and biophysical research communications.

[7]  T. Katada,et al.  Purification, identification, and characterization of two GTP-binding proteins with molecular weights of 25,000 and 21,000 in human platelet cytosol. One is the rap1/smg21/Krev-1 protein and the other is a novel GTP-binding protein. , 1989, The Journal of biological chemistry.

[8]  R. Sagi-Eisenberg.  GTP-binding proteins as possible targets for protein kinase C action. , 1989, Trends in biochemical sciences.

[9]  A. Vinik,et al.  Decreased Platelet Phosphoinositide Turnover and Enhanced Platelet Activation in IDDM , 1989, Diabetes.

[10]  T. K. Harden,et al.  Modification of AlF-4- and receptor-stimulated phospholipase C activity by G-protein beta gamma subunits. , 1989, The Journal of biological chemistry.

[11]  G. King,et al.  Activation of protein kinase C by elevation of glucose concentration: proposal for a mechanism in the development of diabetic vascular complications. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[12]  E. Lapetina,et al.  A ras-related protein is phosphorylated and translocated by agonists that increase cAMP levels in human platelets. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[13]  F. DeRubertis,et al.  Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. , 1989, The Journal of clinical investigation.

[14]  Y. Takai,et al.  Small molecular weight GTP-binding proteins in human platelet membranes. Purification and characterization of a novel GTP-binding protein with a molecular weight of 22,000. , 1989, The Journal of biological chemistry.

[15]  G. Fisher,et al.  Plasma membrane associated phospholipase C from human platelets: synergistic stimulation of phosphatidylinositol 4,5-bisphosphate hydrolysis by thrombin and guanosine 5'-O-(3-thiotriphosphate). , 1989, Biochemistry.

[16]  R. Iyengar,et al.  Beta gamma subunits of GTP-binding proteins inhibit muscarinic receptor stimulation of phospholipase C. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Haslam,et al.  Detection of 23-27 kDa GTP-binding proteins in platelets and other cells. , 1987, The Biochemical journal.

[18]  S. Srivastava,et al.  Phosphorylation of ras oncogene product by protein kinase C. , 1987, Biochemical and biophysical research communications.

[19]  E. Lapetina,et al.  GDPβS enhances the activation of phospholipase C caused by thrombin in human platelets: Evidence for involvement of an inhibitory GTP-binding protein , 1987 .

[20]  R. Ballester,et al.  Phorbol ester- and protein kinase C-mediated phosphorylation of the cellular Kirsten ras gene product. , 1987, The Journal of biological chemistry.

[21]  P. Majerus,et al.  Guanine nucleotides stimulate soluble phosphoinositide-specific phospholipase C in the absence of membranes. , 1986, The Journal of biological chemistry.

[22]  E. Lapetina.  Effect of pertussis toxin on the phosphodiesteratic cleavage of the polyphosphoinositides by guanosine 5'-O-thiotriphosphate and thrombin in permeabilized human platelets. , 1986, Biochimica et biophysica acta.

[23]  E. Lapetina,et al.  GTP and GDP will stimulate platelet cytosolic phospholipase C independently of Ca2+. , 1986, Biochemical and biophysical research communications.

[24]  G. Fisher,et al.  Regulation of membrane-associated and cytosolic phospholipase C activities in human platelets by guanosine triphosphate. , 1986, The Journal of biological chemistry.

[25]  J. Fain,et al.  Regulation of phosphoinositide breakdown by guanine nucleotides. , 1986, Life sciences.

[26]  G. Fisher,et al.  GTP and cytosol stimulate phosphoinositide hydrolysis in isolated platelet membranes. , 1986, Biochemical and biophysical research communications.

[27]  T. Tuvemo,et al.  Platelet Aggregation during the First Year of Diabetes in Childhood , 1985, Acta paediatrica Scandinavica. Supplement.

[28]  S. P. Halenda,et al.  Phorbol myristate acetate inhibits thrombin-stimulated Ca2+ mobilization and phosphatidylinositol 4,5-bisphosphate hydrolysis in human platelets. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[29]  E. Lapetina,et al.  1,2-Diacylglycerol and phorbol ester inhibit agonist-induced formation of inositol phosphates in human platelets: possible implications for negative feedback regulation of inositol phospholipid hydrolysis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[30]  A. H. Drummond,et al.  Tumour‐promoting phorbol esters inhibit agonist‐induced phosphatidate formation and Ca2+ flux in human platelets , 1985, FEBS letters.

[31]  E. Lapetina,et al.  Properties and distribution of phosphatidylinositol-specific phospholipase C in human and horse platelets. , 1983, Biochimica et biophysica acta.

[32]  M. Laimins,et al.  Increased platelet aggregation in early diabetus mellitus. , 1975, Annals of internal medicine.

[33]  H. Kwaan,et al.  Increased platelet aggregation in diabetes mellitus. , 1972, The Journal of laboratory and clinical medicine.

[34]  G. Born,et al.  The aggregation of blood platelets , 1963, The Journal of physiology.

[35]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[36]  R. Haslam,et al.  Roles of GTP-binding proteins and protein kinase C in signal transduction in the platelet. , 1990, Advances in second messenger and phosphoprotein research.

[37]  Bleasdale Je,et al.  Measurement of phosphoinositide-specific phospholipase C activity. , 1990 .

[38]  Y. Banno,et al.  Multiple forms of phosphoinositide-phospholipase C and GTP-binding protein in human platelets. , 1990, Advances in second messenger and phosphoprotein research.

[39]  T. Fischer,et al.  Thrombolamban, the 22-kDa platelet substrate of cyclic AMP-dependent protein kinase, is immunologically homologous with the Ras family of GTP-binding proteins. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[40]  P. Halushka,et al.  Altered platelet function in diabetes mellitus. , 1976, Diabetes.